An adaptive model for developing guidelines is needed to ensure recommendations are actionable and timely Guidelines should help clinicians and patients make better decisions, but too often they do ...

How we are responding to recessive genetic disorders is a positive story, although the public debate might make you doubt this, writes Neil Small Progress in the global response to recessive disorders ...

Background Idiopathic pulmonary fibrosis (IPF) is a progressive disease of lung parenchymal scarring that is triggered by repeated microinjury to a vulnerable alveolar epithelium. It is increasingly ...

Correspondence to Dr Nina Vaezipour, Department of Paediatric Inectious Diseases and Vaccinology, University Childrens Hospital Basel, 4056 Basel, Switzerland; nina.vaezipour{at}ukbb.ch A 12-year-old ...

Objectives The use of cerebral embolic protection (CEP) during transcatheter aortic valve implantation (TAVI) has been studied in several randomised trials. We aimed to perform a systematic review and ...

Objectives We explored whether a spike in running distance during a single session or over 1 week, compared with the preceding period, was associated with increased risk of running-related overuse ...

Correspondence to Dr Marie-Coralie Cornet, Department of Pediatrics, University of California San Francisco, San Francisco, CA 94143, USA; marie-coralie.cornet{at}ucsf.edu Objective Selective ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

Background and aims N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a well-established biomarker in clinical practice, particularly for heart failure, but its role in predicting atrial ...

Objective To investigate the efficacy and safety of open-label placebos (OLP) in premenstrual syndrome (PMS). Design Randomised controlled trial. Setting Switzerland, 2018–2020. Participants 150 women ...